A year of generic PrEP could recoup its own cost within five years if effectiveness is high, Public Health England model finds
PrEP would save the NHS money, in numerous scenarios
HIV diagnoses in the UK fell in gay men last year for the first time since the mid-1990s, Public Health England confirms
People living with HIV in the UK not receiving appropriate monitoring of heart disease risk
Demand for access to NHS PrEP trial looks set to outstrip places
‘Summer’s here… Where is PrEP?’ asks United4PrEP
HIV Manifesto launched today
Switching from Atripla to generic-containing regimens can produce large cost savings